Zylorion Announces Additions to Board of Directors and Advisory Committee
CALGARY, Alta., September 8, 2022 /PRNewswire/ – Zylorion Health Inc., (“Zylorion” or the “Company”), an innovator focused on precision mental health care and psychedelic therapy, is pleased to announce the addition of Mr. Jeroen Tas to the Company’s Board of Directors, along with the addition of Dr. Ted Goldstein to the company’s digital health advisory committee.
“We are extremely pleased to have Mr. Tas and Dr. Goldstein join our company. In addition to being recognized and celebrated as leaders in transformative technology and innovation, Mr. Tas and Dr. Goldstein have a successful track record in entrepreneurship and bring highly relevant and in-depth experience in healthcare, health technology and bioinformatics,” commented Dr. Silverstone StoneChief executive officer.
About Mr. Jeroen Tas
Mr. Tas previously held the position of Director of Innovation and Strategy at Koninklijke Philips NV (“Phillips“) (NYSE: PHG) (AMS: PHIA), a leading global health technology company. Prior to joining Philips, Mr. Tas co-founded and served as President, COO and Vice President of Mphasis Ltd., a global technology solutions company. Mr. Tas also led Transaction Technology Inc., Citi’s technology lab, where he oversaw the first launch of Internet banking, new payment networks and Internet-based self-service devices.
Mr. Tas previously served as a Zylorion Board Observer and a member of the Digital Health Advisory Committee.
About the dr. Ted Goldstein
Dr. Goldstein most recently served as Director of Artificial Intelligence at Elevance Health Inc. (NYSE: ELV), formerly Anthem Inc., where he oversaw the development of “HealthOS”, an artificial intelligence-based healthcare operating system. Dr. Goldstein was previously vice president of software tools at Apple (NASDAQ: AAPL), where he led the team that created the Xcode, Mac OS X and iOS runtime operating systems for Mac and iPhone. Prior to Apple, Dr. Goldstein served as Director of Java Commerce at Sun Microsystems, where he co-created the Java programming language and designed the Java card system used in billions of smart cards.
“We are delighted to welcome Mr. Tas and Dr. Goldstein to our company and look forward to working closely with them, along with the rest of our directors and advisors, to achieve our mission of delivering novel therapies. innovative and effective solutions that will enable people with mental health issues to thrive,” noted Dr Silverstone.
Zylorion is a biotechnology company engaged in the development and delivery of precision integrated mental health therapies to treat psychological and neurological mental health conditions. Zylorion is focused on the research, development and commercialization of psychedelic-based compounds associated with novel therapeutic treatment programs targeting a continuum of mental health disorders, such as MDD (Major Depressive Disorder), TRD (Resistant Depression to treatment), PTSD (post-traumatic stress disorder), general depression, anxiety disorders and a number of addictive tendencies. Zylorion aims to leverage advanced technologies to support the scalability and accessibility of its integrated therapy programs in its mission to empower people with mental health challenges to thrive.
Caution Regarding Forward-Looking Statements
This press release contains statements that constitute forward-looking information (“forward-looking information”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical facts, are forward-looking information and are based on expectations, estimates and projections as of the date of this press release. Any statement that discusses predictions, expectations, beliefs, plans, projections, goals, assumptions, future events, or performance (often, but not always, using expressions such as “s’ expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “expected”, “expects”, “estimates”, “believes” or “intends” or variations of these words and phrases or indicating that certain actions, events or results “may” or “might”, “would”, “might” or “will” be assumed to occur or be realized) are not statements of historical fact and may be forward-looking information.